Plant
metabolites from natural product extracts offer unique advantages
against carcinogenesis in the development of drugs. The target-based
virtual screening from food-derived compounds represents a promising
approach for tumor therapy. In this study, we performed virtual screening
to target the presumed inhibitor-binding pocket and identified a highly
potent Kv10.1 inhibitor, liensinine (Lien), which can inhibit the
channel in a dose-dependent way with an IC50 of 0.24 ±
0.07 μM. Combining molecular dynamics simulations with mutagenesis
experiments, our data show that Lien interacts with Kv10.1 by binding
with Y539, T543, D551, E553, and H601 in the C-linker domain of Kv10.1.
In addition, the interaction of sequence alignment and 3D structural
modeling revealed differences between the C-linker domain of the Kv10.1
channel and the Kv11.1 channel. Furthermore, antitumor experiments
revealed that Lien suppresses the proliferation and migration of HCC
both in vitro and in vivo. In summary, the food-derived compound,
Lien, may serve as a lead compound for antihepatoma therapeutic drugs
targeting Kv10.1.